Praxis Global Alliance

🔴 #PraxisThoughtLeadership 🗞️ 𝐈𝐧𝐝𝐢𝐚'𝐬 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐆𝐞𝐧𝐞𝐫𝐢𝐜 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞 𝐄𝐱𝐩𝐨𝐫𝐭𝐬: 𝐂𝐡𝐞𝐚𝐩𝐞𝐫, 𝐁𝐮𝐭 𝐀𝐫𝐞 𝐓𝐡𝐞𝐲 𝐚𝐬 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐚𝐬 𝐁𝐫𝐚𝐧𝐝𝐞𝐝 𝐎𝐧𝐞𝐬⁣ ⁣⁣⁣⁣ Generic medicines in India undergo a rigorous process to ensure they meet the highest standards of quality, safety, and effectiveness. This process includes research, formulation, bioequivalence studies, and manufacturing under Good Manufacturing Practices (GMP), which collectively ensure that generic medicines are on par with their branded counterparts. In an exclusive interaction with India Today, Madhur Singhal, Managing Partner, Pharma and Lifesciences, Praxis Global Alliance shared his insights on generic medicines. He stated that the process of making generic medicines in India is done in several stages, in which special attention is paid to quality, safety, and effectiveness. Research, formulation, bioequivalence research, and manufacturing under GMP – all these together ensure that generic medicines are at par with branded medicines. He also added that due to the clearances and constant monitoring from CDSCO (Central Drugs Standard Control Organization) under Regulatory Compliance, every medicine is tested on the same standard. This is the reason that whether medicine is general or generic, there is no difference in quality between the two, the only difference is the promotional method. ➡️ At Praxis Global Alliance, we help in guiding companies to navigate the complexities of the pharmaceutical industry! 📌 Tap here to read the exclusive interaction- https://lnkd.in/g8fmp2B5 👉 Story Credit- Apoorva Singh, India Today #GenericMedicines #PharmaceuticalIndustry #IndiaPharma #QualityStandards #RegulatoryCompliance #CDSCO #PraxisinNews #PraxisThoughtLeadership Madhur Singhal| Shivam Bajaj

📶 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐢𝐧𝐭𝐨 𝐭𝐡𝐞 𝐏𝐫𝐢𝐯𝐚𝐭𝐞 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 ⁣ ⁣⁣⁣ The current market dynamics reveal a compelling opportunity for private investments. As of now, only 10% of active companies have successfully secured private funding, signaling a significant potential for growth. Out of the 90,000 active businesses in the market, approximately 9,000 have received investment, leaving a substantial gap for investors looking to capitalize on untapped opportunities. This data underscores the fact that the private investment space is still underpenetrated, providing fertile ground for strategic capital deployment. In a market where the majority of companies remain unfunded, there is a distinct opportunity for investors to position themselves early in high-growth sectors with strong upside potential. By applying a data-driven, targeted approach, investors and stakeholders can unlock substantial value, leveraging insights to make informed decisions that drive superior returns. The current landscape offers a prime moment for those looking to make strategic moves and capitalize on emerging opportunities.  ➡️ Tap here to read more about the current private capital landscape in our latest report 𝐈𝐧𝐝𝐢𝐚 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐏𝐮𝐥𝐬𝐞 -https://lnkd.in/gQVp6s27 #PrivateInvestment #InvestmentStrategy #MarketOpportunities #VentureCapital #StrategicGrowth #BusinessExpansion #CapitalAllocation Akshat Gupta ⁣

#PraxisThoughtLeadership We are elated to share that, Madhur Singhal, Managing Partner & CEO Praxis Global Alliance, led the inaugural session of 𝐌𝐚𝐧𝐭𝐡𝐚𝐧⁣, a structured learning series for IndoSpace employees. The session, titled 𝐀𝐈-𝐏𝐨𝐰𝐞𝐫𝐞𝐝 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧, delved into the profound impact Artificial Intelligence is having on business advisory, value creation, and investment strategies. He engaged the IndoSpace leadership team in a deep, insightful discussion on AI's role in shaping the future and addressed crucial questions about how organizations should respond to the AI revolution, whether it is a genuine opportunity or a passing trend, and how individuals can future-proof their careers in an increasingly automated world. The lively Q&A highlighted the broader psycho-socio-economic implications of AI, further enriching the conversation. At Praxis Global Alliance, we remain committed to helping organizations navigate the complexities of AI, ensuring they make informed, strategic decisions that lead to measurable outcomes. We are here to guide businesses through the entire journey—from conceptualization to impact. #BuildTogetherWinTogether #PraxisIsPractical #AITransformation #LeadershipDevelopment #PraxisThoughtLeadership Madhur Singhal| Anshuman Singh| Moushumi D.

🌸𝐇𝐚𝐩𝐩𝐲 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐖𝐨𝐦𝐞𝐧'𝐬 𝐃𝐚𝐲! Today, we take a moment to honor the incredible strength, resilience, and brilliance that women bring to the world every single day. From nurturing life to leading transformative change, women are the quiet warriors shaping the future with boundless courage, love, and unwavering spirit. At Praxis Global Alliance, we celebrate not only the incredible achievements of women but also the limitless potential they possess to reshape our future. Let’s honor the women who inspire, uplift, and ignite change - today and every day! Wishing you all a truly empowering and joyful International Women’s Day. 𝐁𝐮𝐢𝐥𝐝 𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫. 𝐖𝐢𝐧 𝐓𝐨𝐠𝐞𝐭𝐡𝐞𝐫.⁣⁣ ⁣⁣ #IWD2025 #WomensDay #Empowerment #Leadership #ChangeMakers #Inspiration #Equality #WomenInLeadership Madhur Singhal | Aryaman Tandon Andrea Kallarakal| Poonam Karkera| Mallika Chawla| Aditi Shetty| Trisha Gupta| Chhaya Dhawan| Eshita B| Mishi Bansal| Aiman Fatma| Angel Bansal| Anshika Negi| Ritika Dubey| Sanya Agarwal| Shivangi Gupta| Srishti Sachan| Tamanna Vashist| Rhea Rose Kappan| Sanskriti Agrawal| Kirti Rai ✨

🔴 #PraxisinNews In an exclusive interaction with Katya Naidu,NDTV Profit, insights from the 𝐈𝐧𝐝𝐢𝐚 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬 𝐏𝐮𝐥𝐬𝐞⁣⁣⁣ report by Praxis Global Alliance featured exclusively in NDTV Profit. In 2023, strategic exits by private equity (PE) and venture capital (VC) firms dropped significantly, with exit values falling by 29% and volumes by 40%. This slowdown was driven by the growing appeal of public listings and favorable valuations, leading to reduced deal activity in the private capital space 📶 Some of the key Insights from the report as cited by Akshat Gupta, Practice Member, Private Capital, Praxis Global Alliance were- ➡️ IPO Market Outlook: While IPO activity remains strong, the pace is expected to be more measured. There is sustained demand from retail and institutional investors for scalable, resilient businesses, but companies lacking stability may struggle to attract capital in the public market. ➡️ Rise of Strategic Deals: Indian corporates and MNCs are increasingly pursuing consolidations and acquisitions for scale. This trend, particularly among PE/VC-backed companies, is expected to drive larger transactions in the coming years, fueling growth in strategic deals. The Indian private equity and venture capital market is evolving, with IPOs and strategic acquisitions becoming key drivers of future growth. Businesses will need to focus on scalability and resilience to succeed in this changing landscape. ✅ For more details, read the full insight featured in NDTV Profit here- https://lnkd.in/gFPcKkFH #PrivateEquity #VentureCapital #StrategicExits #Investments #MarketTrends #IPO #PraxisGlobalAlliance #CorporateStrategy #MergersAndAcquisitions #NDTVProfit #PraxisinNews Madhur Singhal| Akshat Gupta| Shivam Bajaj| Katya Naidu| Niraj Shah

#PraxisThoughtLeadership   𝐒𝐭𝐫𝐞𝐧𝐠𝐭𝐡𝐞𝐧𝐢𝐧𝐠 𝐈𝐧𝐝𝐢𝐚'𝐬 𝐏𝐡𝐚𝐫𝐦𝐚 𝐅𝐮𝐭𝐮𝐫𝐞⁣ ⁣ ⁣India has established itself as a dominant force in the global pharmaceutical landscape, earning the prestigious title "Pharmacy of the World." The nation ranks as the third-largest pharmaceutical producer by volume, contributing a substantial 10% to global production. In terms of value, India holds the 14th position globally, representing 1.5% of the world market. In an insightful and comprehensive article in Pharma Industrial India, Ayush Singh, Practice Member, Pharma and Lifesciences, Praxis Global Alliance and Madhur Singhal, Managing Partner, Pharma and Lifesciences, Praxis Global Alliance, explore the critical challenges and opportunities within India’s Active Pharmaceutical Ingredient (API) industry. With a focus on reducing the country's dependency on API imports, they highlight key factors shaping India’s pharmaceutical landscape.India, as a leading global producer of pharmaceuticals, has long played a vital role in the global healthcare supply chain. However, recent disruptions-exacerbated by the pandemic and other geopolitical events have illuminated the vulnerabilities within India’s API supply chain. These challenges underscore the need for a robust and self-sufficient domestic API industry.  ➡️ Some key themes explored in the article include:  📈 Government Initiatives: The authors delve into the proactive steps taken by the Indian government to boost domestic API production, such as the production-linked incentive (PLI) scheme. They also examine other policy measures aimed at fostering growth and resilience in the pharmaceutical sector.  🟣 Supply Chain Vulnerabilities: A detailed analysis of the risks associated with India’s over-reliance on imported raw materials and the potential consequences of disruptions in global trade. The article outlines the urgent need to strengthen local manufacturing capabilities to mitigate these risks. This article provides a thoughtful roadmap for India’s journey toward pharmaceutical self-reliance, offering a clear vision for building a more resilient, competitive, and sustainable sector. ✅ Tap here to read the full article and explore further insights-https://lnkd.in/gNtizxNh #Pharmaceuticals #Lifesciences #API #Healthcare #PraxisThoughtLeadership #PraxisinNews Madhur Singhal| Ayush Singh| Shivam Bajaj| Eugenio Pérez de Lema| Omnimedia| Aishwarya Saxena

#PraxisReport 📶 𝐔𝐧𝐥𝐨𝐜𝐤𝐢𝐧𝐠 𝐕𝐚𝐥𝐮𝐞 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 & 𝐎𝐩𝐞𝐫𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐄𝐱𝐜𝐞𝐥𝐥𝐞𝐧𝐜𝐞⁣ ⁣ ⁣The focus is on driving sustainable value creation by deploying hands-on operational teams and enhancing board involvement for strategic insights. Through executive coaching and mentorship, C-suite executives are empowered to excel. Tailored liquidation strategies, including continuation funds, secondary market solutions, and performance-linked incentives, are crafted to extend holding periods and identify strategic investors, all while maximizing returns. Commitment to profitability and capital efficiency includes optimizing costs, pricing, and working capital, while managing leverage to enhance returns. CFO functions are strengthened, with a focus on preparing for successful exits. Additionally, the fund's network is leveraged to foster strategic partnerships and global access, while enabling peer learning across portfolio companies through specialized forums, workshops, and events. ➡️ Tap here https://lnkd.in/gHCa_43c to read more about India's investment landscape in our latest report- India Investment Pulse! #Leadership #OperationalExcellence #ValueCreation #PrivateEquity #StrategicGrowth #BusinessSuccess #PraxisReport Akshat Gupta

#PraxisinNews 💊𝐈𝐧𝐝𝐢𝐚’𝐬 𝐀𝐏𝐈 𝐒𝐞𝐜𝐭𝐨𝐫: 𝐀 𝐆𝐫𝐨𝐰𝐢𝐧𝐠 𝐏𝐨𝐰𝐞𝐫𝐡𝐨𝐮𝐬𝐞 𝐢𝐧 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬 India's Active Pharmaceutical Ingredients (API) sector is a key pillar of the country's pharmaceutical industry, contributing approximately 35% to the overall market value. As the third-largest global producer of APIs, India holds an 8% market share and manufactures over 500 different APIs. The sector is growing at a robust rate of 8.3% CAGR, with its market expected to expand from $18 billion in 2024 to $22 billion by 2030. According to a recent report by Praxis Global Alliance, India’s Active Pharmaceutical Ingredients (API) market is growing at an impressive CAGR of 8.3% and is set to expand from $18 billion in 2024 to $22 billion by 2030. In conversation with ETCFO, Madhur Singhal, Managing Partner, Pharma and Lifesciences, Praxis Global Alliance stated that, government initiatives like the Production Linked Incentive (PLI) scheme and bulk drug parks are driving significant change, encouraging investments and reducing reliance on imports. As the sector grows, competition for talent is intensifying, especially for management-level roles.He also added that, APIs represent about 35% of India’s pharmaceutical market value, with an average of 40% of drug manufacturing costs tied to these key components. However, the sector faces challenges in storage, transportation, supply chain vulnerabilities, and environmental regulations. ➡️ Click here to read the full conversation with ETCFO- https://lnkd.in/gYyKEyKw #Pharma #API #Healthcare #IndiaPharma #Pharmaceuticals #GlobalMarket #BusinessGrowth #LifeSciences #SupplyChain #PraxisinNews Madhur Singhal| Shivam Bajaj

#PraxisatEvent 📢We are thrilled to announce that Kshiteej Mishra, Practice Member, Mobility Energy and Transportation, Praxis Global Alliance will be the panel moderator for the session "𝐄𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐢𝐧 𝐖𝐢𝐫𝐞𝐥𝐞𝐬𝐬 𝐂𝐡𝐚𝐫𝐠𝐢𝐧𝐠 𝐟𝐨𝐫 𝐄𝐕𝐬⁣ at the 𝐄𝐕 𝐓𝐄𝐂𝐇 𝐈𝐍𝐃𝐈𝐀 𝐄𝐗𝐏𝐎 𝟐𝟎𝟐𝟓⁣ organized by EV TECH INDIA EXPO! 🌱 Expect to witness groundbreaking product launches, deep dive into the future of sustainable EV integration in smart cities and explore how innovative solutions are shaping the future of transportation and technology! The list of eminent panelists include- ● Rajiv Lade, Regional Head, TATA Power ● Sunil Bhambhani, Managing Director, Ador Digatron Pvt. Ltd ● Akshat Modi, Business Head, Exponent Energy ● Niraj Toshniwal, Founder & Director, Piev Solutions Pvt Ltd. ● Akihiro Ueda, CEO, Terra Motors Corporation ● Anurang Dorle, Author, Let's ChargeUp India This 3-day event will bring together global EV enthusiasts, manufacturers, distributors, investors, and policymakers to explore the latest in Electric Vehicle Technologies, Advanced Batteries, Charging Infrastructure, and Energy Storage Systems. 🗓️ Date: 7-9 March 2025 📍 Venue: Auto Cluster Exhibition Centre, Pune 🚀 Join us for a chance to discover the future of #EVCharging, cutting-edge tech, and sustainable solutions at the EV TECH INDIA EXPO 2025! #EVTechIndia #WirelessCharging #SustainableTransport #Innovation #ElectricVehicles #TechExpo #Pune2025 #PraxisatEvent Aryaman Tandon| Kshiteej Mishra| Shivam Bajaj| MUKESH YADAV⚡

India’s investment ecosystem reached a pivotal milestone in 2024, with approximately US$ 60 B deployed across 1,595 deals, showcasing strong investor confidence and highlighting the country's promising growth potential. Growth-stage investments saw a dip, accounting for 17% of total deal activity compared to 26% in 2023. However, these investments still secured US$ 10B across 388 deals, showing that there’s continued interest in scaling businesses. The average deal size decreased by 50% to around US$ 30M, signaling a more disciplined, value-driven approach as investors focus on capital allocation and risk mitigation in a volatile market. US$ 3B was raised by growth funds in 2024, maintaining a 29% share of total fundraising, the highest in five years. This underscores the ongoing investor confidence in India’s growth-stage market. Looking ahead, the outlook for 2025 is extremely positive. With continued momentum in exits, growing deal activity, and increasing fundraising efforts, India remains a key hub for global investors, particularly in high-innovation sectors such as SaaS, AI, ecommerce, BFSI, and healthcare. ➡️ To dive deeper into the latest trends shaping India’s growth equity landscape, download the full report https://lnkd.in/exssVy3H now and stay ahead of the curve! #IndiaInvestments #GrowthEquity #PrivateInvestments #Innovation #SaaS #AI #Ecommerce #BFSI #Healthcare #InvestmentTrends